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Eukaryotic elongation factor 1A (eEF1A) is the only protein modified by ethanolamine phosphoglycerol
(EPG). Inmammals and plants, EPG is attached to conserved glutamate residues located in eEF1A domains
II and III, whereas in the unicellular eukaryote, Trypanosoma brucei, a single EPG moiety is attached to
domain III. A biosynthetic precursor of EPG and structural requirements for EPG attachment to T. brucei
eEF1A have been reported, but the role of this unique protein modification in cellular growth and eEF1A
function has remained elusive. Here we report, for the first time in a eukaryotic cell, a model system to study
potential roles of EPG. By down-regulation of EF1A expression and subsequent complementation of eEF1A
function using conditionally expressed exogenous eEF1A (mutant) proteins, we show that eEF1A lacking
EPG complements trypanosomes deficient in endogenous eEF1A, demonstrating that EPG attachment is
not essential for normal growth of T. brucei in culture.
E
ukaryotic elongation factor 1A (eEF1A) is an essential protein involved in the elongation step of protein
translation, where it delivers aminoacyl-tRNAs to the A-site of the ribosome (reviewed by1). Besides its
pivotal role during protein synthesis, eEF1A is involved in many other cellular processes such as signal
transduction, nuclear export of proteins and mitochondrial tRNA import2–4; in addition, it interacts with com-
ponents of the cytoskeleton5–8. This multi-functionality may not be surprising since eEF1A is one of the most
abundant cellular proteins, comprising 1–3% of total cytosolic protein9, and, as a consequence, is present in large
excess to its ligands in peptide synthesis (molar ratios for eEF1A:eEF1B and eEF1A:ribosomes of 1051 and 2551,
respectively)10.
Covalent protein modifications are ubiquitous in eukaryotic cells, affecting protein folding, maturation, struc-
ture and sub-cellular localization; moreover, they are involved in the regulation of biological activities, including
interactions with other molecules11–13. For eEF1A, several covalent modifications such as phosphorylation14,15,
lysine methylation16,17, and C-terminal methyl-esterification18, have been reported to affect its biological activity
during polypeptide synthesis; however, their precise roles are poorly understood (reviewed by19). In addition,
mammalian and plant eEF1A is modified by two ethanolamine phosphoglycerol (EPG) moieties attached to
conserved glutamic acid residues in domains II and III20–22. Similarly, EPG-modified eEF1A has also been
described in the protozoan parasite, Trypanosoma brucei. T. brucei eEF1A (TbEF1A) is modified with only a
single EPG moiety at Glu362 in domain III however, despite the fact that the second potential EPG modifi-
cation site, Glu289 in domain II, is conserved between trypanosomes, mammals and plants23. Interestingly,
Saccharomyces cerevisiae represents the only eukaryote so far where eEF1A seems not to be modified with
EPG24. This lack of EPG attachment to eEF1A in S. cerevisiae, which represents one of the most commonly used
and best studied eukaryotic model organisms, makes the search for enzymes involved in EPG attachment and the
study of the function of EPG attachment more difficult and challenging.
A study using T. brucei as a model organism to investigate EPG biosynthesis and attachment to eEF1A showed
that the ethanolamine moiety in EPG derives from the phospholipid phosphatidylethanolamine23. In addition,
recently we showed that replacement of Glu362 in TbEF1A completely inhibited the addition of EPG, even if
glutamate was replaced by aspartate, indicating that the enzyme mediating attachment of EPG, or its precursor
molecule, is highly specific for Glu at this position25. Remarkably, although EPG attachment to eEF1A was first
reported more than 20 years ago, the physiological role of this unique protein modification has remained elusive.
In the present study, we describe for the first time a model system to investigate potential roles of EPG in a
eukaryotic cell. We chose T. brucei as model organism to knock down the expression of endogenous TbEF1A
using inducible RNA interference (RNAi), which in T. brucei represents a powerful tool to down-regulate protein
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expression26 and results in complete growth arrest of TbEF1A-
depleted parasites. By complementation experiments using con-
ditionally expressed exogenous eEF1A proteins, we then assessed
the potential of mutated eEF1A to rescue the lethal phenotype.
Using this approach, we demonstrate that eEF1A mutant proteins
lacking the EPG attachment sites restored growth of T. brucei pro-
cyclic culture forms depleted of endogenous TbEF1A.
Results
Since the role of EPG in eEF1A function is unknown, we decided to
establish a model system that would allow the study of EPG function
in cell growth. Development of the system using T. brucei procyclic
forms in culture involved three steps: i) generation of an inducible
RNAi cell line to deplete endogenous TbEF1A, ii) introduction of an
inducible ectopic copy of wild type eEF1A into the RNAi-competent
cell line, as proof-of-principle to demonstrate functional comple-
mentation of endogenous TbEF1A by an ectopic copy, and iii) intro-
duction of an inducible ectopic copy of mutated eEF1A lacking the
EPG attachment site into the RNAi-competent cell line to study EPG
function for parasite growth in culture.
RNAi mediated knock-down of TbEF1A. Expression of TbEF1A
was down-regulated in T. brucei 29-13 procyclic forms by targeting
the intergenic region 1 located between the first and second tan-
demly-arranged TbEF1A gene on chromosome 10 of the T. brucei
genome. After 3 days of induction of RNAi, growth of the parasite
clone C5 stopped completely whereas uninduced cells proliferated
normally (Fig. 1A). Northern blot analysis demonstrated that the
addition of tetracycline resulted in disappearance of the correspond-
ing mRNA (Fig 1B). Protein analysis by immunoblotting using anti-
eEF1A antibody showed complete absence of eEF1A at days 2, 4 and
6 of induction (Fig. 1C, lower panel), whereas eEF1A was con-
tinuously present in control parasites incubated in the absence of
tetracycline (Fig. 1C, upper panel). Similar results (growth curve,
Northern blot, immunoblot) were obtained with a second clone
(results not shown).
Complementation of TbEF1A-depletedT. bruceiwith ectopic wild
type eEF1A. To study if ectopic eEF1A was able to complement
TbEF1A-depleted T. brucei parasites and restore parasite growth in
culture, a tetracycline-inducible ectopic copy of wild type eEF1A was
introduced into the rRNA locus of the TbEF1A RNAi cell line C5.
The addition of tetracycline to parasites in culture was expected to
induce both the RNAi machinery directed against endogenous
TbEF1A and the expression of the ectopic copy of eEF1A. The results
show that growth of the selected clone (C5-E, with E referring to
glutamic acid at position 362 of wild type TbEF1A) in the presence of
tetracycline was similar to that of control cells incubated in the
absence of the antibiotic (Fig. 2A). Northern blot analysis using a
probe against eEF1A intergenic region 1 shows that the primary
transcript was absent after induction with tetracycline for 3 days
(Fig. 2B), demonstrating that RNAi against endogenous TbEF1A
was effective (see also Fig. 1B). Similar results (growth curve,
Northern blot) were obtained with a second clone (results not
shown).
Immunoblot analysis of proteins extracted from eEF1A-comple-
mented parasites C5-E indicates that expression of eEF1A was
severely decreased after 2 days of incubation in the presence of tetra-
cycline (Fig. 2C, upper panel). However, in contrast to the situation
in the RNAi cell line lacking expression of ectopic eEF1A (see Fig. 1C,
lower panel), strong bands of eEF1A were visible after 4 days and 6
days of tetracycline induction (Fig. 2C, upper panel), suggesting that
they represent protein encoded by the ectopic copy of eEF1A.
Because the anti-eEF1A antibody does not discriminate between
endogenous and ectopically expressed eEF1A, we studied the time
course of expression of an ectopic HA-tagged form of eEF1A that
can subsequently be analyzed by immunoblotting using anti-HA
antibody. The results showed that HA-tagged eEF1A in the cell line
Figure 1 | RNAi-mediated silencing of T. brucei eEF1A. (A) To down-
regulate TbEF1A expression, T. brucei procyclic forms were transfected
with an RNAi plasmid targeting the intergenic region 1 of the tandemly
repeated eEF1A genes. The selected clone (C5) was cultured in the absence
(triangles) or presence (diamonds) of tetracycline for 7 days and diluted
daily to a density 33106 cells/ml. (B)Northern blots of total RNA extracted
fromparasites after three days of incubation in the absence (2) or presence
(1) of tetracycline (tet) and hybridized with 32P-labeled probes (top);
rRNA was used as loading control (bottom). (C) SDS-PAGE and
immunoblot analysis of TbEF1A in parasites (clone C5) cultured in the
absence (2) or presence (1) of tetracycline (tet) for 0, 2, 4 and 6 days and
probed with a-EF1A antibody. Each lane contains lysate from 13107 cells.
www.nature.com/scientificreports
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C5-haE can be detected as a faint band after 2 days of incubation in
the presence of tetracycline and as strong bands after 4 and 6 days of
induction (Fig. 2C, lower panel). These data show that re-appearance
of eEF1A in clone C5-E after 4 and 6 days of incubation in the
presence of tetracycline coincides with the time point of expression
of HA-eEF1A in clone C5-haE, suggesting that the eEF1A bands in
clone C5-E likely represent ectopically expressed wild type eEF1A.
Unfortunately, clone C5-haE expressing HA-tagged eEF1A could
not be used for further experiments since HA-eEF1A was unable
to complement endogenous eEF1A and restore parasite growth
(results not shown), indicating that the N-terminal HA-tag inter-
fered with eEF1A function.
To further analyze which forms of eEF1A were transcribed in the
C5-E parasites, we performed RT-PCR using primer pairs allowing
discrimination between RNA derived from genomic TbEF1A and
ectopic eEF1A. Primary transcripts from endogenous TbEF1A con-
tain gene-specific UTR sequences flanking the tandemly arranged
TbEF1A ORFs whereas these sequences are not present in the prim-
ary transcripts from the ectopic copy. The results using a primer pair
hybridizing to the 59UTR and TbEF1A ORF (Supplemental Table
S1) show that mRNA originating from endogenous TbEF1A was
present in clone C5-E at day 0 but absent after 2 days of incubation
in the presence of tetracycline (Fig. 2D, middle panel). In contrast,
the use of a primer pair hybridizing to the TbEF1A ORF showed the
presence of the corresponding mRNA during the entire induction
period (Fig. 2D, top panel), demonstrating that ectopic eEF1A was
transcribed whereas transcription of endogenous TbEF1A was
ablated.
Complementation of TbEF1A-depleted T. brucei with ectopic
eEF1A lacking the EPG modification site. The successful comple-
mentation of the TbEF1A RNAi cell line with wild type eEF1A
demonstrates that the system can be used to study the role of EPG
attachment to eEF1A for growth of T. brucei procyclic forms in
culture by using eEF1Amutant proteins lacking the EPG attachment
site. Based on our previous findings25, we transfected TbEF1A RNAi
cells with ectopic copies of eEF1A in which the glutamate residues
at position 362 were replaced by aspartate (E362D) or glutamine
(E362Q). The results show that growth of parasite clones transfected
with ectopic eEF1A/E362D (clone C5-D) or eEF1A/E362Q (clone
C5-Q) was identical to that of uninduced cells (Fig. 3A and 3B, upper
panels). Northern blot analyses using a probe against TbEF1A inter-
genic region 1 showed that, following induction by tetracycline for 3
days, the endogenous eEF1A transcripts in the clones were effectively
Figure 2 | Complementation of TbEF1A-depleted T. brucei with wild-
type eEF1A. (A) T. brucei procyclic form clone C5-E1 transfected with an
RNAi plasmid against TbEF1A (see Fig 1) and an inducible copy of wild-
type eEF1A was grown in the absence (triangles) or presence (diamonds) of
tetracycline for 7 days. Each day, the cultures were diluted to a cell density
of 33106 cells/ml. (B)Northern blots of total RNA extracted fromparasites
after three days of incubation in the absence (2) or presence (1) of
tetracycline (tet) and hybridized with 32P-labeled probes (top); rRNA was
used as loading control (bottom). (C) SDS-PAGE and immunoblot
analysis of TbEF1A in C5-E parasites (upper panel) and HA-eEF1A in C5-
haE parasites (lower panel) cultured in the presence of tetracycline for 0, 2,
4 and 6 days and probed using a-EF1A and a-HA antibody, respectively.
Each lane contains lysate from 13107 cells. (D) RT-PCR analysis of eEF1A
transcript levels. cDNA generated from parasites cultured in the presence
of tetracycline was amplified using primer pairs Tb2100_WT
(Supplemental Table S1), hybridizing to ectopic TbEF1A (top panel),
Tb2100_59UTR and Tb2100_WT, hybridizing to endogenous TbEF1A
(middle panel), and Tb3360, hybridizing to T. brucei mitochondrial
elongation factor Tu (EFTu; as PCR control; bottom panel), respectively.
Lanes containing cDNA, total RNA as negative control, and genomic DNA
as positive control, are indicated. The numbers above the panels refer to the
culture time of the parasites in presence of tetracycline (in days).
www.nature.com/scientificreports
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down-regulated (Fig. 3A and 3B, lower panels), demonstrating that
RNAi against endogenous TbEF1A was effective. Similar results
(growth curve, Northern blot) were obtained with one additional
clone from each of the two transfections (results not shown). In
addition, as expected immunoblot analyses demonstrated the pres-
ence of eEF1A in protein extracts from clones C5-D and C5-Q
throughout the entire induction period (Fig. 3C). The decreased
intensity of the bands after 2 days of induction with tetracycline
reflects down-regulation of endogenous TbEF1A while expression
of ectopic (mutated) eEF1A is induced (compare with Fig. 2C). The
band at 37 kDa represents a degradation product of eEF1A occa-
sionally seen in preparations23,25,27. Finally, the presence of transcripts
originating from ectopic eEF1A together with the disappearance of
mRNA derived from endogenous TbEF1A confirmed proper func-
tion of the constructs (Fig. 4A and 4B).
Taken together, the results of the growth curves, Northern blots,
immunoblots and RT-PCR experiments demonstrate that the
mutated forms of eEF1A, lacking the EPG attachment site, are able
to complement endogenous TbEF1A and restore normal growth of
TbEF1A-depleted T. brucei procyclic forms in culture.
Discussion
Normally, a given protein modification is present simultaneously on
many different proteins within a cell. Thus, approaches to knock out
enzymes or other essential components involved in the synthesis or
attachment of a modification may not only affect the protein of
interest but many other proteins as well. Remarkably, eEF1A is the
only protein so far that is modified with EPG20,22,28. However, the
biosynthetic route for the synthesis and attachment of EPG is still
unknown, although the phospholipid, phosphatidylethanolamine,
has been identified as the donor of the ethanolamine moiety of
EPG23. Furthermore, the function of EPG is completely unknown.
In the present report, we describe for the first time a model system to
study possible roles of EPG in eEF1A function in a eukaryotic cell. As
model organism we chose the protozoan parasite, T. brucei, since
i) EPG in TbEF1A has been structurally characterized23, ii) TbEF1A,
in contrast to eEF1A in other eukaryotes, contains a single EPG
modification site only23, iii) point mutations of the EPG attachment
site of TbEF1A, Glu362, have been shown to abolish EPG binding25,
and iv) T. brucei is amenable to genetic manipulation, such as RNAi,
inducible gene expression and knock-out or knock-in strategies29–31.
First we generated a tetracycline-inducible T. brucei cell line, in
which expression of endogenous TbEF1A was ablated by RNAi di-
rected against the intergenic region 1, located between the first and
second TbEF1A gene on chromosome 10. Induction of RNAi by
tetracycline resulted in complete disappearance of TbEF1A mRNA
and protein, resulting in growth arrest of parasites in culture. These
results are in line with a study in which expression of TbEF1A was
down-regulated by RNAi directed against the ORF of TbEF1A4. In a
second step, we successfully rescued the growth defect by introducing
Figure 3 | Complementation of TbEF1A-depleted T. brucei with eEF1A
lacking the EPG attachment site. (A, B) T. brucei procyclic forms carrying
an RNAi plasmid against TbEF1A (see Fig. 1) were transfected with an
inducible copy of eEF1A in which the EPG attachment site, Glu362, has
been mutated to aspartate (E362D; clone C5-D; panel A) or glutamine
(E362Q; C5-Q; panel B). Parasites were cultured in the absence (triangles)
or presence (diamonds) of tetracycline for 7 days and diluted each day to a
cell density of 33106 cells/ml (top panels in A, B). The lower panels in A
and B show Northern blots of total RNA extracted from parasites after
three days of incubation in the absence (2) or presence (1) of tetracycline
(tet) and hybridized with 32P-labeled probes (top); rRNA was used as
loading control (bottom). (C) SDS-PAGE and immunoblot analysis of
eEF1A in C5-D (upper panel) andC5-Q (lower panel) parasites cultured in
the presence of tetracycline for 0, 2, 4 and 6 days and probed using a-EF1A
antibody. Each lane contains lysate from 13107 cells.
www.nature.com/scientificreports
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a tetracycline-inducible ectopic copy of wild type eEF1A into the
RNAi cell line. After tetracycline-dependent ablation of endogenous
TbEF1A and expression of ectopic eEF1A, growth of T. brucei pro-
cyclic forms was unchanged compared to uninduced control cells.
The result demonstrates that ectopically expressed wild type eEF1A
is able to complement endogenous TbEF1A function in parasites in
culture. Finally, we studied if eEF1A, in which the EPG attachment
site, Glu362, was replaced by Asp or Gln, was able to rescue eEF1A-
depleted RNAi parasites. The results show that this is the case, i.e.
both eEF1A/E362D and eEF1A/E362Q restored growth of T. brucei
procyclic forms depleted of endogenous TbEF1A, indicating that
attachment of EPG to TbEF1A is not necessary for normal growth
of T. brucei under standard culture conditions.
The non-essentiality of EPG attachment to TbEF1A for parasite
growth in culture raises the question why this unique protein modi-
fication has evolved and has been maintained in eukaryotes during
evolution. The synthesis and attachment of EPG likely involves mul-
tiple gene products and metabolites, and thus, is a costly event for a
cell to maintain. Similar considerations also apply for two other
unique protein modifications, diphthamide attachment to eukaryo-
tic elongation factor 2 (eEF2) and hypusine linkage to eukaryotic
initiation factor 5A (eIF5A) (reviewed by32). Interestingly, although
these modifications – like EPG – have been reported for the first time
more than 30 years ago33,34, their roles in protein function have also
remained elusive. Similar to the situation for EPG attachment to
eEF1A in T. brucei, modification of eEF2 with diphthamide is not
strictly required for growth of yeast andmammalian cells35–38, despite
the fact that this modification is conserved from archaea to humans.
It has been proposed that essential functions of diphthamide may
only become evident under certain conditions, e.g. in the context
of a multi-cellular organism or during stress39–41. For instance, S.
cerevisiae strains lacking diphthamide attachment to eEF2 were
found to have increased frequency in ribosomal (-)1 frame shifting42.
Furthermore, Chinese hamster ovary cells lacking genes involved in
diphthamide biosynthesis were three-fold more sensitive towards
ricin than wild type cells, suggesting that diphthamide may protect
ribosomes from ribosome-inactivating proteins43. Accordingly, it is
possible that the roles for EPG in eEF1A function will only become
apparent under stress conditions, or in the natural environment of
the parasite. In contrast to EPG and diphthamide, hypusine has
been reported to be essential for cell viability in S. cerevisiae44–46,
Leishmania donovani47 and multi-cellular organisms48,49. Neverthe-
less, its role in eIF5A function, which recently has been shown to
promote translation elongation rather than translation initiation
(reviewed by50) is not known.
Methods
Unless otherwise specified, all reagents were of analytical grade and were fromMerck
(Darmstadt, Germany), Sigma-Aldrich (Buchs, Switzerland) or ICN Biomedicals
(Ta¨gerig, Switzerland). DNA polymerase was obtained from Invitrogen (Basel,
Switzerland). Restriction enzymes were purchased from Roche Diagnostics
(Rotkreuz, Switzerland), Fermentas (St. Leon-Rot, Germany), or New England
Biolabs (Ipswich, MA). [a-32P]dCTP, and Bio-Max MS films were from GE
Healthcare, Kodak MBX films and TransScreen-HE intensifying screen from Kodak
(Lausanne, Switzerland).
Constructs. RNAi directed against TbEF1A was done using the pALC14 vector, a
pLew-100-based stem loop construct containing a puromycin resistance gene51. The
two fragments inserted in opposite direction into pALC14 represent the intergenic
region 1 between the tandemly arranged TbEF1A genes, Tb927.10.2090 and
Tb927.10.2100 (TriTrypDB, Tb92710v5, location 546408-547232). For tetracycline-
inducible expression of the ectopic copy of TbEF1A, the open reading frame (ORF) of
Tb927.10.2100 was first subcloned into pBluescript. Subsequently, the glutamate
residue at position 362 was mutated to aspartate or glutamine, as previously
described25. Hemagglutinin (HA)-tagged TbEF1A was cut out from pEGhaEF(1-449)25
using restriction enzymes BamHI and HindIII. Wild type, HA-tagged and mutated
TbEF1A ORFs were then cloned between BamHI and HindIII restriction sites of
pALC14 carrying a blasticidin gene. All constructs were sequenced before
transfection. The primers used to amplify the TbEF1A intergenic region 1 and
Figure 4 | RT-PCR analysis of eEF1A transcript levels in mutant parasites expressing EPG-deficient eEF1A. cDNA generated from eEF1A/E362D (A)
and eEF1A/E362Q (B) parasites (see Fig 3) cultured in the presence of tetracycline was amplified using primer pairs Tb2100_WT (Supplemental Table
S1), hybridizing to mutated ectopic eEF1A (top panels), Tb2100_59UTR and Tb2100_WT, hybridizing to endogenous TbEF1A (middle panels), and
Tb3360, hybridizing toT. brucei elongation factor Tu (EFTu; as PCR control; bottompanels), respectively. Lanes containing cDNA, total RNA as negative
control, and genomic DNA as positive control, are indicated. The numbers above the panels refer to the culture time of the parasites in presence of
tetracycline (in days).
www.nature.com/scientificreports
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TbEF1A ORF, as well as those used for site-directed mutagenesis, are listed in
Supplemental Table S1. All constructs were linearized with NotI prior to transfection.
Cell culture. T. brucei procyclic form strain 29–13 was grown at 27uC in SDM79
supplemented with 15% fetal bovine serum and 25 mg/ml hygromycin and
15 mg/ml G-418 to maintain constitutive expression of the T7 RNA polymerase and
the tetracycline repressor29. Parasites were grown to a maximum density of 1.33107
cells/ml.
Transgenic cell lines. RNAi cell lines against TbEF1A intergenic region 1 were
selected with 2 mg/ml puromycin. One of the positive clones, named C5, was selected
for transfections with the plasmids allowing tetracycline-inducible ectopic expression
of TbEF1A proteins. The resulting transfectants were selected in the presence of 10
mg/ml blasticidin. Formation of double-stranded RNA and conditional expression of
TbEF1A proteins were induced by the addition of 1 mg/ml tetracycline. Stable
transfection, selection of transfectants, and production of clonal cell lines were done
as described previously25.
Northern blot analysis. Total RNA for Northern blotting was isolated using a SV
Total RNA Isolation System (Promega, Madison,WI) and 10 mg of the total RNAwas
separated on formaldehyde-agarose gels (1% agarose, 2% formaldehyde in 20 mM 3-
(N-morpholino)propanesulfonic acid). To control for equal loading, ribosomal RNA
was visualized on the same gel by ethidium bromide staining. Subsequently, the RNA
was transferred to positively charged nylon membrane, Hybond-N1 (GE Healthcare,
Glattbrugg, Switzerland). 32P-Labeled probe against polycistronic TbEF1A mRNA
was made by random priming using the PCR product of the TbEF1A intergenic
region 1 (Prime-a-Gene Labeling System, Promega). Hybridization was performed
overnight at 60uC in 0.5 M Na2HPO4, pH 7.2, containing 7% (w/v) SDS, 1% (w/v)
bovine serum albumin, and 0.9 mM EDTA. The membrane was analyzed by
autoradiography using Bio-Max MS film and a TransScreen-HE intensifying screen.
Immunoblot analysis. Proteins were extracted using Nonidet P-40 as described
before25. Extracted proteins were separated by glycine-SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) under reducing conditions using 12% polyacrylamide
gels52. Semi-dry blotting was performed as previously described25. A mouse
monoclonal antibody against eEF1A (Upstate, Lake Placid, NY) and a secondary
rabbit anti-mouse IgG antibody conjugated to horseradish peroxidase (Dako, Baar,
Switzerland) were used at dilutions of 155000. Labeled proteins were detected by
enhanced chemiluminescence (Pierce, Lausanne, Switzerland).
Reverse transcription PCR analysis. To assess TbEF1A transcript levels, reverse
transcription-PCR (RT-PCR) was performed. Total RNA was collected from
parasites at the time when the induction using tetracycline was started (day 0) and
48 hrs (day 2), 96 hrs (day 4) and 144 hrs (day 6) after induction. The synthesis of
complementary DNA (cDNA) from single-stranded RNA was done according to the
manufacturer’s guidelines using SuperScriptH II Reverse Transcriptase and
Oligo(dT)20 Primer (Invitrogen) using 1mg of extracted total RNA. Subsequent
amplification of cDNA was done using 20 cycles of denaturation (95uC for 30 s),
annealing (50uC for 30 s) and extension (72uC for 60 s). The cDNA originating from
the transcripts of both endogenous and ectopic TbEF1A was detected using primers
Tb2100_WT forward and Tb2100_WT reverse (Supplemental Table S1), which
match the nucleotide sequences located at the beginning and end, respectively, of the
TbEF1A ORF. To detect the cDNA originating from endogenous TbEF1A only,
primer Tb2100_59UTR (Supplemental Table S1) was used in combination with the
above mentioned reverse primer. Total RNA extract was used as a negative control.
To control for equal loading, RT-PCRwas done in parallel with a primer pair (Tb3360
forward and reverse; Supplemental Table S1) binding to the ORF of T. brucei
elongation factor Tu (TriTrypDB, Tb927.10.13360). As a positive control for the PCR
reaction and for the size of the amplified sequence, genomic DNA from the T. brucei
strain 29-13 was used. Reaction products were semi-quantified by electrophoresis
using 0.8% agarose gel.
1. Merrick, W. C. Eukaryotic protein synthesis: still a mystery. J Biol Chem 285,
21197–21201 (2010).
2. Panasyuk, G., Nemazanyy, I., Filonenko, V., Negrutskii, B. & El’skaya, A. V. A2
isoform of mammalian translation factor eEF1A displays increased tyrosine
phosphorylation and ability to interact with different signalling molecules. Int J
Biochem Cell Biol 40, 63–71 (2008).
3. Khacho, M. et al. eEF1A is a novel component of the mammalian nuclear protein
export machinery. Mol Biol Cell 19, 5296–5308 (2008).
4. Bouzaidi-Tiali, N., Aeby, E., Charriere, F., Pusnik, M. & Schneider, A. Elongation
factor 1a mediates the specificity of mitochondrial tRNA import in T. brucei.
EMBO J 26, 4302–4312 (2007).
5. Liu, G. et al. Interactions of elongation factor 1alpha with F-actin and beta-actin
mRNA: implications for anchoring mRNA in cell protrusions. Mol Biol Cell 13,
579–592 (2002).
6. Murray, J. W., Edmonds, B. T., Liu, G. & Condeelis, J. Bundling of actin filaments
by elongation factor 1 alpha inhibits polymerization at filament ends. J Cell Biol
135, 1309–1321 (1996).
7. Gross, S. R. & Kinzy, T. G. Translation elongation factor 1A is essential for
regulation of the actin cytoskeleton and cell morphology. Nat Struct Mol Biol 12,
772–778 (2005).
8. Gross, S. R. & Kinzy, T. G. Improper organization of the actin cytoskeleton affects
protein synthesis at initiation. Mol Cell Biol 27, 1974–1989 (2007).
9. Merrick, W. C. & Hershey, J. W. B. The pathway and mechanism of eukaryotic
protein synthesis in Translational Control, edited by J. W. B. Hershey, M. B.
Mathews, & N. Sonnenberg (Cold Spring Harbor Laboratory Press, New York,
1996), pp. 31–69.
10. Kaur, K. J. & Ruben, L. Protein translation elongation factor-1 alpha from
Trypanosoma brucei binds calmodulin. J Biol Chem 269, 23045–23050 (1994).
11. Walsh, C. T., Garneau-Tsodikova, S. & Gatto, G. J., Jr. Protein posttranslational
modifications: the chemistry of proteome diversifications. Angew Chem Int Ed
Engl 44, 7342–7372 (2005).
12. Seet, B. T., Dikic, I., Zhou,M.M.& Pawson, T. Reading proteinmodifications with
interaction domains. Nat Rev Mol Cell Biol 7, 473–483 (2006).
13. Ahrne´, E., Mu¨ller, M. & Lisacek, F. Unrestricted identification of modified
proteins using MS/MS. Proteomics 10, 671–686 (2010).
14. Chang, Y. W. & Traugh, J. A. Insulin stimulation of phosphorylation of
elongation factor 1 (eEF-1) enhances elongation activity. Eur J Biochem 251, 201–
207 (1998).
15. Peters, H. I., Chang, Y. W. & Traugh, J. A. Phosphorylation of elongation factor 1
(EF-1) by protein kinase C stimulates GDP/GTP-exchange activity. Eur J Biochem
234, 550–556 (1995).
16. Dever, T. E., Costello, C. E., Owens, C. L., Rosenberry, T. L. & Merrick, W. C.
Location of seven post-translational modifications in rabbit elongation
factor 1 alpha including dimethyllysine, trimethyllysine, and
glycerylphosphorylethanolamine. J Biol Chem 264, 20518–20525 (1989).
17. Fonzi, W. A., Katayama, C., Leathers, T. & Sypherd, P. S. Regulation of protein
synthesis factor EF-1 alpha in Mucor racemosus. Mol Cell Biol 5, 1100–1103
(1985).
18. Zobel-Thropp, P., Yang, M. C., Machado, L. & Clarke, S. A novel post-
translational modification of yeast elongation factor 1A. Methylesterification at
the C terminus. J Biol Chem 275, 37150–37158 (2000).
19. Ejiri, S. Moonlighting functions of polypeptide elongation factor 1: from actin
bundling to zinc finger protein R1-associated nuclear localization. Biosci
Biotechnol Biochem 66, 1–21 (2002).
20. Whiteheart, S. W., Shenbagamurthi, P., Chen, L., Cotter, R. J. & Hart, G. W.
Murine elongation factor 1alpha is posttranslationally modified by novel amide-
linked etanolamine-phosphogycerol moieties. J Biol Chem 264, 14334–14341
(1989).
21. Ransom, W. D., Lao, P.-C., Gage, D. A. & Boss, W. F.
Phosphoglycerylethanolamine posttranslational modification of plant eukaryotic
elongation factor 1alpha. Plant Physiol 117, 949–960 (1998).
22. Rosenberry, T. L. et al. Biosynthetic incorporation of [3H]ethanolamine into
protein synthesis elongation factor 1alpha reveals a new post-translational protein
modification. J Biol Chem 264, 7096–7099 (1989).
23. Signorell, A., Jelk, J., Rauch, M. & Bu¨tikofer, P. Phosphatidylethanolamine is the
precursor of the ethanolamine phosphoglycerol moiety bound to eukaryotic
elongation factor 1A. J. Biol. Chem. 283, 20320–20329 (2008).
24. Cavallius, J., Zoll,W., Chakraburtty, K. &Merrick,W. C. Characterization of yeast
EF-1 alpha: non-conservation of post-translational modifications. Biochim
Biophys Acta 1163, 75–80 (1993).
25. Greganova, E., Heller, M. & Bu¨tikofer, P. A structural domain mediates
attachment of ethanolamine phosphoglycerol to eukaryotic elongation factor 1A
in Trypanosoma brucei. PLoS One 5, e9486 (2010).
26. Bellofatto, V. & Palenchar, J. B. RNA interference as a genetic tool in
trypanosomes. Methods Mol Biol 442, 83–94 (2008).
27. Regmi, S., Rothberg, K. G., Hubbard, J. G. & Ruben, L. The RACK1 signal anchor
protein fromTrypanosoma brucei associates with eukaryotic elongation factor 1A:
a role for translational control in cytokinesis. Mol Microbiol 70, 724–745 (2008).
28. Tisdale, E. J. & Tartakoff, A. M. Extensive labeling with [3H]ethanolamine of a
hydrophilic protein of animal cells. J Biol Chem 263, 8244–8252 (1988).
29. Wirtz, E., Leal, S., Ochatt, C. & Cross, G. A. A tightly regulated inducible
expression system for conditional gene knock-outs and dominant-negative
genetics in Trypanosoma brucei. Mol Biochem Parasitol 99, 89–101 (1999).
30. Ullu, E., Tschudi, C. & Chakraborty, T. RNA interference in protozoan parasites.
Cell Microbiol 6, 509–519 (2004).
31. Wirtz, E. & Clayton, C. Inducible gene expression in trypanosomes mediated by a
prokaryotic repressor. Science 268, 1179–1183 (1995).
32. Greganova, E., Altmann, M. & Bu¨tikofer, P. Unique modifications of translation
elongation factors. FEBS J 278, 2613–2624 (2011).
33. Van Ness, B. G., Howard, J. B. & Bodley, J. W. ADP-ribosylation of elongation
factor 2 by diphtheria toxin. NMR spectra and proposed structures of ribosyl-
diphthamide and its hydrolysis products. J Biol Chem 255, 10710–10716 (1980).
34. Shiba, T., Mizote, H., Kaneko, T., Nakajima, T. & Kakimoto, Y. Hypusine, a new
amino acid occurring in bovine brain. Isolation and structural determination.
Biochim Biophys Acta 244, 523–531 (1971).
35. Kimata, Y. & Kohno, K. Elongation factor 2 mutants deficient in diphthamide
formation show temperature-sensitive cell growth. J Biol Chem 269, 13497–13501
(1994).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 254 | DOI: 10.1038/srep00254 6
36. Phan, L. D., Perentesis, J. P. & Bodley, J. W. Saccharomyces cerevisiae elongation
factor 2.Mutagenesis of the histidine precursor of diphthamide yields a functional
protein that is resistant to diphtheria toxin. J Biol Chem 268, 8665–8668 (1993).
37. Liu, S., Milne, G. T., Kuremsky, J. G., Fink, G. R. & Leppla, S. H. Identification of
the proteins required for biosynthesis of diphthamide, the target of bacterial ADP-
ribosylating toxins on translation elongation factor 2.Mol Cell Biol 24, 9487–9497
(2004).
38. Ivankovic, M., Rubelj, I., Matulic, M., Reich, E. & Brdar, B. Site-specific
mutagenesis of the histidine precursor of diphthamide in the human elongation
factor-2 gene confers resistance to diphtheria toxin.Mutat Res 609, 34–42 (2006).
39. Chen, C. M. & Behringer, R. R. Ovca1 regulates cell proliferation, embryonic
development, and tumorigenesis. Genes Dev 18, 320–332 (2004).
40. Liu, S. et al. Dph3, a small protein required for diphthamide biosynthesis, is
essential in mouse development. Mol Cell Biol 26, 3835–3841 (2006).
41. Kruse, M. et al. Inhibition of CD83 cell surface expression during dendritic cell
maturation by interference with nuclear export of CD83 mRNA. J Exp Med 191,
1581–1590 (2000).
42. Ortiz, P. A., Ulloque, R., Kihara, G. K., Zheng, H. & Kinzy, T. G. Translation
elongation factor 2 anticodon mimicry domain mutants affect fidelity and
diphtheria toxin resistance. J Biol Chem 281, 32639–32648 (2006).
43. Gupta, P. K., Liu, S., Batavia, M. P. & Leppla, S. H. The diphthamide modification
on elongation factor-2 renders mammalian cells resistant to ricin. Cell Microbiol
10, 1687–1694 (2008).
44. Schnier, J., Schwelberger, H. G., Smit-McBride, Z., Kang, H. A. & Hershey, J. W.
Translation initiation factor 5A and its hypusinemodification are essential for cell
viability in the yeast Saccharomyces cerevisiae.Mol Cell Biol 11, 3105–3114 (1991).
45. Wohl, T., Klier, H., Ammer, H., Lottspeich, F. & Magdolen, V. The HYP2 gene of
Saccharomyces cerevisiae is essential for aerobic growth: characterization of
different isoforms of the hypusine-containing protein Hyp2p and analysis of gene
disruption mutants. Mol Gen Genet 241, 305–311 (1993).
46. Sasaki, K., Abid, M. R. & Miyazaki, M. Deoxyhypusine synthase gene is essential for
cell viability in the yeast Saccharomyces cerevisiae. FEBS Lett 384, 151–154 (1996).
47. Chawla, B. et al. Identification and characterization of a novel deoxyhypusine
synthase in Leishmania donovani. J Biol Chem 285, 453–463 (2010).
48. Sugimoto, A. High-throughput RNAi in Caenorhabditis elegans: genome-wide
screens and functional genomics. Differentiation 72, 81–91 (2004).
49. Nishimura, K., Lee, S. B., Park, J. H. & Park, M. H. Essential role of eIF5A-1 and
deoxyhypusine synthase inmouse embryonic development.Amino Acids in press
(2011).
50. Kaiser, A. Translational control of eIF5A in various diseases.Amino Acids in press
(2011).
51. Bochud-Allemann, N. & Schneider, A. Mitochondrial substrate level
phosphorylation is essential for growth of procyclic Trypanosoma brucei. J Biol
Chem 277, 32849–32854 (2002).
52. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of
bacteriophage T4. Nature 227, 680–685 (1970).
Acknowledgements
The work was supported by Swiss National Science Foundation grant 31003A-130815 to
P.B. We thank I. Roditi and D. Purple for comments on the manuscript and valuable input
and P. Ma¨ser for support.
Authors contributions statement
EG and PB designed the experiments and wrote the manuscript. EG performed the
experiments.
Additional information
Supplementary information accompanies this paper at http://www.nature.com/
scientificreports
Competing financial interests: The authors declare no competing financial interests.
License: This work is licensed under a Creative Commons
Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this
license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
How to cite this article: Greganova, E. & Bu¨tikofer, P. Ethanolamine phosphoglycerol
attachment to eEF1A is not essential for normal growth of Trypanosoma brucei. Sci. Rep. 2,
254; DOI:10.1038/srep00254 (2012).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 2 : 254 | DOI: 10.1038/srep00254 7
